Clinical Trial Update: Endocan in Ventilator-associated Pneumonia

View source ↗

Summary

Clinical trial update examining endocan as a biomarker in ventilator-associated pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Snippet

Sponsor: Erzincan University | Conditions: Serial Endocan Measurements | Status: UNKNOWN